Connection
Frits Van Rhee to Immunosuppressive Agents
This is a "connection" page, showing publications Frits Van Rhee has written about Immunosuppressive Agents.
|
|
Connection Strength |
|
 |
|
 |
|
0.069 |
|
|
|
-
Barlogie B, van Rhee F, Shaughnessy JD, Epstein J, Yaccoby S, Pineda-Roman M, Hollmig K, Alsayed Y, Hoering A, Szymonifka J, Anaissie E, Petty N, Kumar NS, Srivastava G, Jenkins B, Crowley J, Zeldis JB. Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease. Blood. 2008 Oct 15; 112(8):3122-5.
Score: 0.069